TAKASHI KIYOIZUMI, M.D.
Medical Practice at Holly Leaf Ct, San Diego, CA
License number
California 53320
Category
Medical Practice
Type
Plastic Surgery
Address
Address
17231 Holly Leaf Ct, San Diego, CA 92127
Phone
(858) 756-9828
Personal information
See more information about TAKASHI KIYOIZUMI at radaris.comName
Address
Phone
2741 Eastview Ter, Escondido, CA 92025
Rancho Santa Fe, CA
San Diego, CA
Professional information
Life Science Executive/Entrepreneur
Position:
Member at BioPacific Investors, Managing Member at ROSY LLC, Member at Life Science Angels
Location:
Greater San Diego Area
Industry:
Biotechnology
Work:
BioPacific Investors
-
Member
ROSY LLC
- Greater San Diego Area since Feb 2012
-
Managing Member
Life Science Angels
since 2006
-
Member
San Diego Symphony
2006 - 2009
-
Director of the Board
TechCoast Angels
2006 - 2008
-
Member
Trius Therapeutics
2005 - 2008
-
Director of the Board
MediciNova, Inc.
2000 - 2005
-
President & CEO
Tanabe Research Laboratories, USA
2000 - 2002
-
President and CEO
Indevus Pharmaceuticals
1994 - 2000
-
SVP, Business Development & Strategic Planning
ImmuLogic Pharmaceutical Corporation
1991 - 1994
-
Manager, Business Development
Keio University School of Medicine
1981 - 1989
-
Assistant Professor
Harvard Medical School
- Boston, MA Jun 1983 - Oct 1984
-
Surgical Research Fellow
Education:
Massachusetts Institute of Technology - Sloan School of Management 1989 - 1991
SM, Business Administration and Management, General Keio University 1975 - 1981
MD, PhD, Medicine
SM, Business Administration and Management, General Keio University 1975 - 1981
MD, PhD, Medicine
Skills:
Biotechnology, Strategic Planning, Life Sciences, Start-ups, Fundraising, Lifesciences, CEOs, Entrepreneurship, IPO, Clinical Development, Oncology, Corporate Development, Clinical Trials, Venture Financing, Pharmaceutical Industry, Drug Discovery, Drug Development, Mergers, Venture Capital, Technology Transfer, Regulatory Affairs, Executive Management, R&D, Immunology, Commercialization, M&A experience, Licensing, CRO, Biopharmaceuticals, Infectious Diseases, Medical Devices
Dr. Takashi Kiyoizumi, San Diego CA - MD (Doctor of Medicine)
Specialties:
Family Medicine
Address:
17231 Holly Leaf Ct, San Diego 92127
(858) 756-9828 (Phone)
(858) 756-9828 (Phone)
Languages:
English
Phenoxyalkycarboxylic Acid Derivatives In The Treatment Of Ulcerative Colitis
US Patent:
7786169, Aug 31, 2010
Filed:
Sep 29, 2008
Appl. No.:
12/240678
Inventors:
Kenneth Walter Locke - Carlsbad CA, US
Charles G. Smith - Rancho Santa Fe CA, US
Takashi Kiyoizumi - San Diego CA, US
Charles G. Smith - Rancho Santa Fe CA, US
Takashi Kiyoizumi - San Diego CA, US
Assignee:
MediciNova, Inc. - San Diego CA
International Classification:
A61K 31/192
US Classification:
514571
Abstract:
A method of treating ulcerative colitis in a patient suffering therefrom comprising: administering an effective amount of a compound selected from compound 1, its metabolite 2 and pharmaceutically acceptable salts or esters thereof:.
Phenoxyalkylcarboxylic Acid Derivatives In The Treatment Of Irritable Bowel Syndrome
US Patent:
8026282, Sep 27, 2011
Filed:
May 7, 2010
Appl. No.:
12/776032
Inventors:
Kenneth Walter Locke - Carlsbad CA, US
Charles G. Smith - Rancho Sante Fe CA, US
Takashi Kiyoizumi - San Diego CA, US
Charles G. Smith - Rancho Sante Fe CA, US
Takashi Kiyoizumi - San Diego CA, US
Assignee:
Medicinova, Inc. - San Diego CA
International Classification:
A61K 31/192
US Classification:
514571
Abstract:
A method of treating irritable bowel syndrome in a patient suffering therefrom comprising: administering an effective amount of a compound selected from compound 1, its metabolite 2 and pharmaceutically acceptable salts or esters thereof:.
Phenoxyalkycarboxylic Acid Derivatives In The Treatment Of Inflammatory Diseases
US Patent:
2005023, Oct 27, 2005
Filed:
Apr 27, 2005
Appl. No.:
11/115225
Inventors:
Kenneth Locke - Carlsbad CA, US
Charles Smith - Rancho Santa Fe CA, US
Takashi Kiyoizumi - San Diego CA, US
Charles Smith - Rancho Santa Fe CA, US
Takashi Kiyoizumi - San Diego CA, US
Assignee:
MEDICINOVA, INC. - San Diego CA
International Classification:
A61K031/12
US Classification:
514689000
Abstract:
A method of treating interstitial cystitis, irritable bowel syndrome, ulcerative colitis, and other inflammatory conditions, comprising: administering to a patient in need thereof an effective amount of a compound selected from compound 1, its metabolite 2 and pharmaceutically acceptable salts or prodrugs thereof: